Kinnos is a biotechnology company that makes it easy to use disinfectants correctly.
Kinnos has raised $15.0M in total funding. The most recent round was Series B. The last funding was announced in May 2023.
Kinnos's investors include Walgreens Boots Alliance, VentureWell, Golden Seeds, Partnership Fund for New York City, New York Angels.
Kinnos is headquartered in Brooklyn, United States.
Kinnos is a biotechnology company that makes it easy to use disinfectants correctly.
Kinnos is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kinnos — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/kinnos. Accessed September 14, 2026.
VCBacked. (2023). Kinnos — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/kinnos
{{cite web |title=Kinnos — Funding & Investors |url=https://www.vcbacked.co/company/kinnos |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated